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Staphylococcus aureus is an important opportunistic human pathogen that is highly resistant to 
osmotic stresses. In order to survive an increase in osmolarity, bacteria immediately take up 
potassium and small organic compounds, also referred to as compatible solutes. The second 
messenger c-di-AMP binds to several receptor proteins, most of which are involved in ion and 
potassium uptake, that help bacteria cope with osmotic stress. In this study, we identified 
OpuCA, the ATPase component of an uptake system for the compatible solute carnitine, as a c-
di-AMP target protein in S. aureus and found that a strain overproducing c-di-AMP showed 
reduced carnitine uptake. The CBS domains of OpuCA bound to c-di-AMP, and a crystal 
structure revealed a putative binding pocket for c-di-AMP in the cleft between the two CBS 
domains. Thus, c-di-AMP is involved in regulating both branches of osmoprotection (potassium 




Signaling nucleotides are key molecules utilized by bacteria to coordinate different 
cellular processes in order to rapidly respond to environmental changes. Cyclic diadenosine 
monophosphate (c-di-AMP) is one such signaling nucleotide produced predominantly by Gram-
positive bacteria (1, 2). This di-nucleotide is produced from two molecules of adenosine 
triphosphate (ATP) by diadenylate cyclase enzymes containing an N-terminal DisA domain and 
degraded to 5’-phosphoadenylyl (3’à5’)-adenine  (pApA) or adenosine monophosphate (AMP) 
by phosphodiesterase enzymes containing either DHH-DHHA1 domains or a His-Asp (HD) 
domain (3-5). In Staphylococcus aureus, c-di-AMP is produced by the adenylate cyclase DacA 
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and degraded by the phosphodiesterase GdpP and intracellular c-di-AMP concentrations of 2 to 8 
µM have been determined (6-8). For optimal bacterial growth, fine control of intracellular c-di-
AMP concentration is critical because both high and low concentrations negatively impact 
proliferation (7, 9, 10). Indeed, in various Gram-positive bacteria, it has been shown that c-di-
AMP production is essential for growth in rich medium (7, 10, 11). In Listeria monocytogenes it 
has been reported that the absence of c-di-AMP leads to a metabolic imbalance and a toxic 
accumulation of the stringent response alarmones (p)ppGpp, which causes growth arrest (12). 
However, the exact molecular details leading to the metabolic imbalance have not yet been 
established, and it is also not known if a similar mechanism exists in other bacteria. 
c-di-AMP functions as signaling molecule by binding to and regulating the activity of 
specific receptor proteins. One essential receptor is the central carbon metabolism enzyme 
pyruvate carboxylase (PC) of L. monocytogenes (13). Other c-di-AMP target proteins identified 
in L. monocytogenes include NrdR, a transcription repressor controlling the expression of 
deoxyribonucleotide biosynthesis genes as well as CbpA and CbpB, cystathionine beta synthase 
(CBS) domain pair proteins of unknown function (13). While this work was in revision, OpuCA, 
the ATPase component of the osmolyte uptake system OpuC, and yet another CBS domain 
protein, was identified as additional c-di-AMP receptor in L. monocytogenes (14). The first 
protein found to bind c-di-AMP was the Mycobacterium smegmatis protein DarR, a transcription 
factor that controls the expression of genes involved in fatty acid biosynthesis (15). Another 
class of c-di-AMP target protein is the PII-like signal transduction protein known as PstA in L. 
monocytogenes and S. aureus or DarA in Bacillus subtilis (13, 16, 17). Whereas several apo- and 
nucleotide-bound structures have been solved for these proteins, their cellular functions are still 
unknown (17-20). 
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The remaining known c-di-AMP target proteins are part of ion transport systems or are 
involved in the regulation of ion transport (16). Specifically, these include the S. aureus sensor 
histidine kinase KdpD, which is required to activate the expression of genes encoding 
components of the ATPase-type potassium uptake system Kdp (16). c-di-AMP binds to the 
universal stress protein (USP) domain in KdpD, and this may inhibit KdpD function (21). Other 
target proteins are the B. subtilis and S. aureus KtrA proteins (also referred to as KtrC in S. 
aureus) and a homologous protein in S. pneumoniae called CabP (16, 22). These proteins are the 
cytoplasmic gating components of a second type of potassium transport system (16, 22). c-di-
AMP binding to these potassium transporter gating components is also thought to inhibit 
potassium uptake (16, 22). c-di-AMP interacts with the C-terminal RCK_C domain in KtrA (16, 
23). This domain is also present in the S. aureus monovalent cation-proton antiporter CpaA, 
which may catalyze the efflux of Na+ or K+ from the cytoplasm in exchange for extracellular H+ 
(16, 24, 25). In this case, c-di-AMP binding has been reported to increase the activity of the 
antiporter (24). Altogether these findings suggest that c-di-AMP inhibits potassium uptake and 
reduces cellular potassium concentrations. 
Potassium uptake systems and cation-proton antiporters together with transporters of 
specific amino acids and small organic molecules (compatible solutes) are key components 
helping bacteria to cope with environmental pH fluctuations and high salt or osmolality 
conditions. As an immediate response to an increase in the extracellular salt concentration, 
bacteria take up potassium to counteract the toxic accumulation of Na+ in the cell and to prevent 
the efflux of water (26, 27). In addition to potassium uptake, bacteria also acquire or synthesize 
compatible solutes such as glycine-betaine, choline, carnitine and proline (27, 28).  
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In this work, we identified OpuCA, a component of the cytoplasmic ATPase that 
functions in the S. aureus ATP-binding cassette transport system OpuC, as new c-di-AMP 
receptor protein. We show that c-di-AMP interacts specifically and with physiologically relevant 
strength with the C-terminal CBS domain of OpuCA. We further show that the S. aureus OpuC 
system is a functional carnitine uptake system and present evidence that high intracellular 
concentrations of c-di-AMP inhibit carnitine uptake. With this we provide experimental evidence 
that both arms of osmoprotection – the potassium and osmolyte uptake systems – are part of the 
c-di-AMP regulatory network.  
 
RESULTS 
Binding of c-di-AMP to the CBS domain of S. aureus OpuCA 
In previous work, we identified three c-di-AMP target proteins, (KtrA, KdpD and PstA) using 
the differential radial capillary action of ligand assay (DRaCALA) with an S. aureus ORFeome 
library that enables the production of 2,335 N-terminally His-tagged proteins from S. aureus 
strain COL in E. coli (16). Here, we screened an S. aureus COL ORFeome library of 2,337 
histidine and maltose binding protein (His-MBP)–tagged fusion proteins (29) in an attempt to 
identify additional c-di-AMP–interacting proteins. The DRaCALA screen was performed in 96-
well format (16, 29, 30) and, as expected, positive interactions were detected for the His-MBP-
KtrA, His-MBP-KdpD and His-MBP-PstA fusion proteins. In addition, we detected an 
interaction between c-di-AMP and the His-MBP-SACOL2453 fusion protein (Fig. S1). SACOL-
2453 corresponds to protein SAUSA300_2393 in S. aureus strain FPR3757 and is annotated as 
OpuCA. opuCA is one of four genes in the opuCA-opuCD operon (Fig. 1A), which encodes the 
ATP-binding cassette osmoprotectant uptake system OpuC. The OpuC system is composed of 
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the transmembrane components OpuCB and OpuCD, a predicted lipoprotein OpuCC, serving as 
substrate binding protein, and OpuCA, constituting the cytoplasmic ATPase component (Fig. 
1B). To confirm that OpuCA is indeed a bona fide c-di-AMP target protein, we isolated the 
plasmid from the E. coli library strain and confirmed that its sequence corresponded to opuCA 
before introducing the plasmid into a E. coli strain T7IQ. We induced production of the His-
MBP-OpuCA fusion protein and purified it by Ni-NTA affinity and size exclusion 
chromatography. The purified protein solutions ranged in concentration from 50 µM to 0.1 µM 
and were diluted two-fold for use in DRaCALAs.  DRaCALAs revealed a Kd of 2.46 ± 0.14 µM 
for the interaction of c-di-AMP with the purified His-MBP-OpuCA fusion protein (Fig. 1C). 
This interaction was specific to c-di-AMP, because only an excess of unlabelled c-di-AMP, but 
not an excess of other nucleotides, could compete with radiolabeled c-di-AMP for binding to 
His-MBP-OpuCA (Fig. 1D). Taken together, these data indicate that the S. aureus OpuCA 
protein is a c-di-AMP–binding protein that interacts specifically and with physiological strength 
with this signaling nucleotide. 
The ATPase domain of OpuCA spans amino acids 38-194, and the two cystathione beta synthase 
(CBS) modules are at amino acids 251 to 302 (CBS1) and 314 to 363 (CBS2) (Fig. 2A). CBS 
domains are usually found in pairs, and hereafter we collectively refer to this pair as the CBS 
domains. To determine which domain of OpuCA interacts with c-di-AMP, we generated 
constructs for expressing and purifying the ATPase and CBS domains separately. We purified 
the His-MBP, His-MBP-OpuCA, His-MBP-ATPase (OpuCA residues 1 to 262), and His-CBS 
(OpuCA residues 237 to 408) fusion proteins alongside the His-MBP and His-MPB-OpuCA 
control proteins (Fig. 2B). These purified proteins were subsequently used in DRaCALAs with 
radiolabeled c-di-AMP. This analysis revealed that c-di-AMP interacted with the CBS domain of 
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OpuCA but not the ATPase domain (Fig. 2C). His-CBS interacted with c-di-AMP with a Kd of 
2.86 ± 0.14 µM (Fig. 2D). This interaction was specific because only an excess of unlabelled c-
di-AMP, but not any of the other nucleotides tested, could compete for binding (Fig. 2E). 
 
c-di-AMP interaction with other S. aureus CBS domain–containing proteins 
Two L. monocytogenes proteins of unknown function that each consist of a stand-alone CBS 
domain, CbpA (Lmo0553 in strain EGD-e) and CbpB (Lmo1009 in strain EGD-e), have been  
identified as c-di-AMP receptors (13). No stand-alone CBS domain protein is predicted to be 
encoded in the S. aureus COL genome. However, besides OpuCA, the conserved domain 
database (CDD) contains six other S. aureus COL proteins that contain CBS domains in addition 
to other domains. Specifically, these proteins are predicted to encode the inosine-5’ 
monophosphate dehydrogenase GuaB (SACOL0460), two membrane proteins with unknown 
functions (SACOL0762 and SACOL0921), the magnesium transporter MgtE (SACOL1013), the 
transcription factor CcpN (SACOL1621), and a multi-domain cytoplasmic protein of unknown 
function (SACOL1752). Sequence alignments comparing the CBS domains of OpuCA with the 
CBS domains of these other S. aureus proteins (including 10 the amino acids flanking each end 
of the CBS domains) revealed that these domains share only 10–23 % sequence identity (Fig. 
3A). E. coli strains producing a His-MBP fusion to four of these proteins [SACOL0460 (GuaB), 
SACOL0921, SACOL1013 (MgtE), and SACOL1621 (CcpN)] were present in the S. aureus 
ORFeome library, however none of these fusion proteins interacted with c-di-AMP in the initial 
screen. To confirm the absence of interaction with c-di-AMP, we verified the sequence of the 
inserts of these clones. In addition, we constructed plasmids pVL847-SACOL0762, pVL847-
SACOL0921, and pVL847-SACOL1013 to overexpress only the CBS domains of these 
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transmembrane proteins in E. coli in order to reduce the likelihood of misfolding and increase 
protein production. We also constructed plasmid pVL847-SACOL1752 because this protein was 
not present in the ORFeome library used for the initial screen. Subsequently, we optimized the 
growth conditions so that protein bands could be detected on a Coomassie stained gel for all His-
MBP fusion proteins (Fig. 3B). Next, we performed DRaCALAs with these E. coli lysates and 
found that OpuCA, but none of the other S. aureus proteins containing CBS domains, bound to 
c-di-AMP (Fig. 3C). To exclude the possibility that some proteins were present in inclusion 
bodies and therefore inaccessible for binding to c-di-AMP, lysates were cleared of insoluble 
inclusion bodies by centrifugation (Fig. S2A) and DRaCALAs repeated using lysates lacking 
insoluble proteins. None of the cleared lysates, including those from cells expressing OpuCA, 
exhibited detectable binding to c-di-AMP (Fig. S2B). However, the observation that whole 
lysates from cells expressing OpuCA bound to c-di-AMP indicates that proteins are still able to 
interact with c-di-AMP even if they are present in insoluble aggregates. Taken together, these 
data show that c-di-AMP interacts specifically with the paired CBS domain of OpuCA, but does 
not interact with other S. aureus proteins that contain CBS domains under the same experimental 
conditions. 
 
Crystal structure of the S. aureus OpuCA CBS domain 
To gain insight into the structure of the c-di-AMP–binding CBS domain in S. aureus OpuCA, we 
purified and crystallized the His-CBS fusion protein, which contains OpuCA residues 237 to 408 
(Fig. 4A, 4B and Table S1). The CBS1 (residues 250-306) and CBS2 (residues 320-369) 
modules have a highly similar βαββα fold and can be superimposed with a total rmsd of 0.75 Å 
(Fig. 4A). The CBS1 and CBS2 domains are connected by a linker region to form a so-called 
		 9	
“Bateman” fold, as seen in other paired CBS domain pair structures (31). The N- and C-terminal 
portions of His-CBS (residues 237-249 and 370-408 of OpuCA, respectively) were not observed 
in the electron density map, suggesting that these regions are disordered. The crystal structure 
was solved as a tetramer in the asymmetric unit, but further inspection showed that the 
asymmetric unit was composed of two distinct protein dimers (Fig. S3A). An analysis with the 
PdbePISA server (32) revealed that a large surface area of ~800 Å2 was buried at the monomer-
monomer interface, suggesting that dimerization might be physiologically relevant rather than 
merely a result of crystallization. Indeed, a size-exclusion chromatography–multi-angle light 
scattering (SEC-MALS) analysis of the purified His-CBS protein, which is 21.8 kDa in size, 
indicated that the protein is dimeric in solution, because the migration of the protein 
corresponded to an ~36 kDa protein complex (Fig. S3B). To find structural homologues of the 
OpuCA CBS domain, we submitted the coordinates to the PdbeFold server (33). The CBS 
domain protein MJ0100 from Methanocaldococcus jannaschii (PDB code 3KPB) was identified 
as the closest homologue with a Z-score of 8.6 and an rmsd of ~1.7 Å. We solved the structure of 
MJ0100 in complex with its ligand S-Adenosyl-Methionine (SAM), which bound in a cleft 
between CBS1 and CBS2 (Fig. 4C) (34). Several other “Bateman” module structures in either an 
apo or ligand-bound form are available (35). In most cases, the ligand is AMP, ADP, ATP or 
SAM, and the nucleotide is bound at a site equivalent to the SAM-binding site in MJ0100. The 
adenine base of SAM in MJ0100 was stabilized by hydrophobic residues, whereas the ribose 
moiety made polar contacts with D439 (34) (Fig. 4C). An electrostatic potential calculation of 
the MJ0100 SAM-binding site using APBS (36) showed that the binding site has a positively 
charged electrostatic surface (Fig. 4D). A structural overlay of the OpuCA CBS domain with the 
MJ0100 protein, followed by APBS analysis, showed that the OpuCA CBS domain also has a 
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positively charged cleft at the location corresponding to the SAM binding site in protein MJ0100 
(Fig. 4D). This suggests that the binding site for the c-di-AMP ligand might be at a similar 
location. A structure-based sequence alignment of ten CBS domain structures solved in a 
nucleotide ligand–bound form (Fig. S4), revealed that in all cases the ligand was bound in a cleft 
between the β2-α2 region of CBS1 and the α1-β1-β2 region of CBS2. However, no unique 
nucleotide binding amino acid motif could be identified. Taken together, our data show that the 
S. aureus OpuCA CBS has a typical “Bateman” fold and, based on analogy with other 
nucleotide-binding CBS domains, we speculate that the c-di-AMP ligand might bind at a cleft 
between the CBS domain pair. 
 
Identification of OpuCA variants unable to bind c-di-AMP 
Next, we set out to identify amino acid residues in OpuCA that are important for c-di-AMP 
binding. In the absence of a structure of OpuCA in complex with c-di-AMP, we made use of 
information from previously solved structures of c-di-AMP binding proteins in complex with the 
nucleotide ligand (13, 17-20, 23, 24). In most cases aromatic amino acids including tyrosine 
(Tyr, Y) or phenylalanine (Phe, F) residues provided key base stacking interactions with the 
nucleotide ligand. To test if aromatic amino acids are also essential for the interaction of c-di-
AMP with the CBS domain of OpuCA, residues Phe283, Phe294, Tyr319, Tyr365 and Trp369 were 
individually mutated to alanines. In addition, two variants of the CBS domain with C-terminal 
deletions were made by truncating the protein at position 365 (CBSΔ365) or 374 (CBSΔ374). 
We produced the respective His-tagged CBS variants in E. coli and prepared lysates from these 
strains as well as from E. coli strains producing wild-type His-CBS or containing an empty 
pET28b vector as positive and negative controls, respectively. Although the exact amount of 
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overproduced protein His-tagged CBS protein variants cannot be quantified in crude extracts, 
aliquots of these lysates were analyzed by gel electrophoresis, to confirm qualitatively that 
similar amounts of protein were produced (Fig. 5A). Next, the lysates were diluted 1:10 and used 
in DRaCALAs to assess the ability of the different variants to interact with c-di-AMP (Fig. 5B). 
Three variants, specifically the His-CBSF283A and His-CBSF294A single amino acid substitution 
variants and the CBSΔ365 variant, showed drastically reduced binding. Attempts to purify His-
CBSΔ365 failed, indicating that this protein does no longer fold properly, and hence this variant 
was not further characterized. On the other hand, His-CBSF283A and His-CBSF294A were readily 
purified by Ni-NTA and size exclusion chromatography. Next, we set out to determine the 
binding affinities between c-di-AMP and the purified variants. At the highest protein 
concentration some binding was observed for His-CBSF283A and His-CBSF294A, saturation was 
not reached, hence no actual Kd values could be determined for these variants binding to c-di-
AMP (Fig. 5C). Taken together, this analysis suggests that Phe283 and Phe294 might interact with 
the c-di-AMP ligand. Next, the locations of the Phe283 and Phe294 residues were mapped onto the 
S. aureus OpuCA CBS crystal structure. Both residues are located within the cleft, which 
corresponds to the nucleotide-binding site in other CBS domain proteins solved in the presence 
of the ligand. This structural analysis combined with the mutagenesis study indicates that the 
aromatic amino acids Phe283 and Phe294 play a critical role in nucleotide binding. In addition, the 
location of these residues on the structure further supports the notion that c-di-AMP binds to 
OpuCA in a positively charged groove located at the interface between CBS1 and CBS2.  
 
Physiological characterization of the S. aureus OpuC transporter 
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To assess the physiological function of the OpuC transporter in S. aureus, we conducted uptake 
assays. A previous study by Kiran et al., suggested that the S. aureus OpuC system is a choline 
transporter (37). We therefore tested the uptake of radiolabeled choline as described in Kiran et 
al. (37) using the wild-type S. aureus strain LAC* (WT), LAC* cells lacking opuCA (ΔopuCA), 
and a complementation strain in which OpuCA was expressed from a plasmid in DopuCA cells 
(opuCA complementation). Radiolabeled choline accumulated over time in samples derived from 
the WT strain, showing that choline is taken up by S. aureus (Fig. 6A). However, the rate of 
choline uptake was identical for the WT, DopuCA, and opuCA complementation strains, 
suggesting that the OpuC system is not the main choline uptake system in S. aureus (Fig. 6A). 
To minimize the amount of available compatible solutes in the medium while also increasing the 
osmotic stress, we repeated the experiment in chemically defined medium (CDM) containing 0.5 
M NaCl. Choline was taken up efficiently, but again there was no difference in the uptake rate 
between the WT, ΔopuCA mutant, and opuCA complementation strain (Fig. 6B). We confirmed 
by Western-blot the production of OpuCA protein in the WT strain grown under these conditions 
(Fig. S5). As expected, the protein was absent in the ΔopuCA strain and again present at slightly 
reduced amounts compared to WT in the opuCA complementation strain (Fig. S5). Next we 
tested if the OpuC system is involved in the uptake of the compatible solutes glycine betaine or 
carnitine, which have been shown to be substrates for the B. subtilis and L. monocytogenes OpuC 
systems, respectively (38, 39). As seen for choline, radiolabelled glycine betaine was taken up at 
a similar rate by the WT, ΔopuCA, and opuCA complementation strains, indicating that the OpuC 
system is not the main glycine betaine uptake system in S. aureus (Fig. 6C). In contrast, 
accumulation of radiolabelled carnitine was only observed in the WT and opuCA 
complementation strains but not in the ΔopuCA strain, indicating that the OpuC system is the 
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main carnitine uptake system in S. aureus (Fig. 6D). Finally, to test whether c-di-AMP plays a 
role in influencing the activity of the OpuC transporter, carnitine uptake was compared between 
the WT LAC* stain and strain LAC*DgdpP, which was previously reported to produce 
approximately 10-fold higher intracellular concentrations of c-di-AMP (2, 7). The accumulation 
of carnitine was measured over 4 hours. A significant reduction in the amount of retained 
radiolabeled carnitine was observed for the DgdpP strain at early time points (t = 1 h and 2 h) 
(Fig. 6E). The total amount of carnitine retained in the WT and DgdpP strains was similar at later 
time points, presumably reflecting the steady state. Taken together, these data suggest that c-di-
AMP negatively impacts the activity of the S. aureus OpuC transporter. 
 
DISCUSSION 
Osmotic stress has a profound impact on the structure, chemistry, and physiology of a 
bacterial cell. Therefore, osmotic stress adaption and tolerance mechanisms are key for the 
survival and growth of bacteria in their natural environments (27). As a countermeasure to an 
osmotic upshift, bacteria take up potassium ions and osmolytes (27). The two main potassium 
transport systems in S. aureus are the Ktr- and Kdp-type transporters (40, 41). Components of 
both these systems have been identified as receptor proteins for the signaling nucleotide c-di-
AMP (16). Here, we identified the S. aureus OpuCA protein, a cytoplasmic ATPase component 
of an osmolyte uptake system, as an additional c-di-AMP target protein (Figs. S1 and 1). With 
this, we implicate this signaling molecule as a potential regulator of both arms of osmoprotection 
in this organism. 
Bacteria can accumulate many different types of osmolytes, including glycine betaine, 
choline, proline, trehalose, and carnitine (42). We found that the uptake of carnitine is abolished 
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in an opuCA mutant strain (Fig. 6D), suggesting that OpuC is the main or only functional 
carnitine uptake system in S. aureus under the conditions tested. In contrast to a previous report 
(37), choline accumulated in the wild-type and the opuCA deletion strain at nearly identical rates 
in our hands (Figs. 6A and 6B). Several different Opu transporters have been identified in B. 
subtilis and their substrate specificity and role in the osmotic stress tolerance characterized (43). 
The three main types are the multi-component ATP-binding cassette transport systems OpuA, 
OpuB, and OpuC, the homo-trimeric BCCT-type glycine betaine transporter OpuD, and the 
sodium:solute symporter family (SSF) proline transporter OpuE (28, 43). Much less is known 
about the various osmoprotectant uptake systems in S. aureus. Our bioinformatics analysis 
suggests that, in addition to OpuC, S. aureus encodes a second ATP-binding cassette transport 
system (Fig. S6). This system is most closely related to the B. subtilis OpuB system and will 
therefore be referred to as such. It is composed of the cytoplasmic ATPase component OpuBA 
and the membrane and periplasmic substrate-binding fusion protein OpuBB-BC (Fig. S6). 
Furthermore, S. aureus has three distinct BCCT-type transport systems, here referred to as 
OpuD1, OpuD2 and BccT (or CudT) (Fig. S6). Although these BCCT-type transporters are most 
closely related to systems that transport choline, glycine betaine, or both, it has been shown that 
OpuD1 is also a low-affinity proline uptake system (44). Lastly, a sodium-solute symporter 
family (SSF) transporter called PutP is present in S. aureus (Fig. S6). PutP is a high affinity 
proline uptake system and its expression is activated under high osmolarity conditions and 
during infection of murine and human tissues (45). Of these systems, we identified only the 
OpuC osmoprotectant uptake system as a target for c-di-AMP. Using a strain producing high 
concentrations of c-di-AMP, we present experimental evidence that suggests that this signaling 
nucleotide negatively impacts carnitine uptake (Fig. 6E). Additional work is required to better 
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define the roles of the different osmoprotectant uptake systems in S. aureus osmotic stress 
adaption, to determine whether OpuC is indeed the only osmoprotectant transporter that is part of 
the c-di-AMP signaling network, and to investigate the biological importance of c-di-AMP–
mediated regulation of OpuC during osmotic stress adaption and infection. 
c-di-AMP binds specifically to the C-terminal CBS domains of the S. aureus OpuCA 
protein (Fig. 2). The CBS domains in OpuAA of the Lactococcus lactis OpuA system have an 
important regulatory function and serve as a sensor of the intracellular ionic strength (46-48). 
Under low ionic strength conditions, positively charged surface-exposed residues in this domain 
are thought to interact with the anionic phospholipids in the membrane, resulting in low transport 
activity (48). High ionic strength is thought to interrupt this membrane interaction, leading to 
increased transport activity (48). However, these positively charged regulatory residues are 
absent in the S. aureus OpuCA protein, indicating that the regulatory mechanism is likely very 
different between these systems. Based on the results presented in this study, we suggest that c-
di-AMP and perhaps even other nucleotides can post-transcriptionally regulate CBS-domain–
containing ATP-binding cassette Opu transporters. It is unclear to what extent and how c-di-
AMP modulates the activity of the S. aureus OpuC system. From a mechanistic point of view, it 
seems plausible that binding of c-di-AMP to the CBS domain would influence the ATPase 
activity of OpuCA and thereby regulate uptake rates. To address this question, further in vitro 
investigations are needed. When we overproduced and purified the full-length OpuCA protein, 
the protein had very weak ATPase activity, which was not sensitive to the concentration of c-di-
AMP. Therefore, for further studies on the regulation of transporter activity it is likely that the 
full ABC transporter complex in a lipid environment will required to reconstitute ATPase 
activity comparable to native hydrolysis rates.  
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CBS domains are not only present in bacterial proteins, they are important regulatory 
domains found in many functionally unrelated proteins across all domains of life (35, 49). 
Several hereditary human diseases have been linked to mutations in CBS domains, hence 
enzymes and transporters containing such domains have been the focus of numerous biochemical 
and structural studies (see reviews (35, 49)). From these studies it is known that CBS domains 
usually come in pairs (as observed in the S. aureus OpuCA protein), assume a “Bateman” fold, 
and can bind different nucleotide ligands, most often in a cleft formed between the CBS1 and 
CBS2 domains (see review (35)). The structure presented in this work revealed that the S. aureus 
OpuCA CBS1 and CBS2 domains assume the expected “Bateman” fold (Fig. 4 and S3). 
Although we were only to obtain the apo-structure at this point, we can still make inferences as 
to the location of the c-di-AMP binding site, based on mutagenesis experiments performed in 
this study and available structures of other CBS domains that have been determined in a ligand-
bound state. A positively charged cleft is formed in OpuCA between the CBS1 and CBS2 
domains (Fig. 4D), matching the SAM binding pocket of MJ0100 and the AMP-binding site in 
other CBS domain proteins (34, 35), indicating that c-di-AMP could bind here. Furthermore, 
changing two phenylalanine residues in this proposed binding pocket, Phe283 and Phe294, to Ala 
drastically decreased the binding affinity for c-di-AMP (Fig. 5). This is presumably due to 
abolishing a base stacking interaction between the side chain of these amino acids and the 
adenine base in c-di-AMP. Up to now three different CBS domain proteins have been identified 
as specific c-di-AMP target proteins; namely the L. monocytogenes standalone CBS domain 
proteins of unknown function CbpA and CbpB (13) and the S. aureus OpuCA protein. However, 
these three c-di-AMP binding CBS domain proteins share only limited similarity at the sequence 
level and have no readily identifiable, specific c-di-AMP binding motif. Therefore, it is currently 
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not possible to predict in silico which CBS-domain–containing proteins will interact specifically 
with c-di-AMP without performing binding experiments. While this manuscript was in revision, 
the OpuCA protein from L. monocytogenes was also identified as c-di-AMP receptor protein and 
the structure of its CBS domains in the c-di-AMP bound state reported (14). In the L. 
monocytogenes protein, one c-di-AMP nucleotide was bound per OpuCA dimer with the two 
adenine bases contacting the protein in a cleft between the CBS1 and CBS2 domains within each 
monomer (14). It will be interesting to investigate in future work whether the nucleotide binding 
sites are identical in both proteins, particularly because the dimer configuration appeared to be 
quite different for the two proteins (14). It is noteworthy that in L. monocytogenes a total of three 
CBS-domain proteins, the multi-domain protein OpuCA and the stand-alone CBS domain 
proteins CbpA and CbpB, have thus far been implicated as c-di-AMP receptor proteins  (13, 14). 
In S. aureus, which lacks standalone CBS-domain proteins, OpuCA was the only CBS-domain 
protein to show binding to c-di-AMP in DRaCALAs (Fig. 3). Other S. aureus multi-domain CBS 
proteins did not bind c-di-AMP in DRaCALAs, suggesting that these other CBS-domain 
containing proteins likely are not c-di-AMP receptors.  
 For several bacterial species, it has now been shown that an increase in intracellular c-di-
AMP concentrations leads to salt hypersensitivity (16, 50), but the molecular mechanism leading 
to this phenotype is not yet completely understood. The identification of components of 
potassium transport systems and now of an osmolyte uptake system as c-di-AMP receptors 
brings us a step closer, as inhibition of such transporters will lead to a decrease in osmotic stress 
tolerance. Increased intracellular c-di-AMP concentrations have also been associated with an 
increased resistance to heat, antibiotics, and low pH, processes in which potassium and osmolyte 
transporters also have important functions (4, 16, 50-54). Appropriate adjustments in cellular 
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potassium concentrations are key for pH homeostasis and maintenance of membrane potential, 
and osmolytes have been implicated not only in osmotic stress tolerance but also in resistance to 
heat or cold, because their accumulation helps to stabilize proteins under these stress conditions. 
Why in this case increased c-di-AMP concentrations and an interaction of c-di-AMP with 
potassium and osmolyte transporter components leads to increased heat or cold resistance 
warrants further investigation. But clearly the identification and characterization of additional c-
di-AMP receptor proteins, as conducted in this study, is an important step towards elucidating 




MATERIALS AND METHODS 
Bacterial strains and growth conditions 
Bacterial strains used in this study are listed in Table S2. E. coli strains were grown in Lysogeny 
Broth (LB) or LB-M9 (49.3 mM Na2HPO4, 14.7 mM KH2PO4, 8.55 mM NaCl, 18.7 mM NH4Cl, 
3.7 mM Na succinate, 11.1 mM glucose, 2 mM MgSO4, 1% tryptone, 0.5% yeast) medium and 
S. aureus strains in Tryptic Soy Broth (TSB), Chemically Defined Medium (CDM) or M9 
medium at 37°C with aeration (180 rpm). The M9 medium was prepared as described in (55) 
with 0.2% glucose as the carbon source, 2% casamino acids, and vitamin supplements (0.1 mg/L 
biotin, 2 mg/L thiamine, 2 mg/L nicotinic acid, 2 mg calcium pantothenate). CDM was prepared 
with glycerol (5.645 g/L) as the carbon source as previously reported (56), with the following 
modifications: sodium pantothenate was replaced with calcium pantothenate, FeCl3 was replaced 
with FeSO4 x 7H2O, and NaCl was added at concentrations stated in the text. In addition, 22 
mg/L CaCl2 x 2H2O and 10 mg/L MnSO4 x 4H2O were added. When appropriate, media were 
supplemented with antibiotics as listed in Table S2. The methicillin-resistant S. aureus (MRSA) 
strain COL Gateway Clone Set (NR-19277), recombinant in E. coli and arrayed in twenty-five 
96-well plates, was obtained through BEI Resources, National Institute of Allergy and Infectious 
Diseases (NIAID), National Institutes of Health (NIH). The library is comprised of 2,343 E. coli 
strains with individual S. aureus COL ORFs in the gateway donor vector pDONR221. The 
construction of the His-MBP fusion protein overproduction library in the gateway destination 
vector pVL847-Gn (conferring gentamycin resistance; (57)) and introduction into the 
chloramphenicol resistant E. coli protein strain T7IQ is described in Corrigan et al., 2016 (29). 
The final His-MBP S. aureus COL ORF fusion protein overproduction library consisted of 2,337 
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strains, as 6 gateway reactions were unsuccessful (plate 3 well A3, B7, D2; plate 6 well C2, plate 
8 well E1 and plate 19 well D11). 
Construction of E. coli protein overproduction strains 
Primers used for strain and plasmid construction are listed in Table S3. Plasmid pVL847-
SACOL2453, from here on out referred to as pVL847-OpuCA was isolated from the original 
His-MBP S. aureus COL ORFeome library strain and retransformed into the E. coli strain T7IQ 
to yield strain ANG3128. This strain was used for the production and purification of the His-
MBP-OpuCA fusion protein. Plasmid pET28b-CBS was constructed for the production and 
purification of the His-CBS protein. Primer pair ANG1842/ANG1785 and LAC* genomic DNA 
were used to amplify the opuCA region coding for amino acids 237 to 408 (CBS domain). The 
resulting PCR product was digested with NheI and EcoRI and inserted into vector pET28b cut 
with the same enzymes. Plasmid pET28b-CBS was initially recovered in strain XL-1 Blue and 
subsequently introduced for protein production into strain BL21(DE3), yielding strains 
ANG3199 and ANG3218, respectively. Plasmids pET28b-CBSF283A, pET28b-CBSF294A, 
pET28b-CBSY319A, pET28b-CBSY365A and pET28b-CBSW369A for the production and purification 
of the different His-CBS single amino acid substitution variants were constructed by site directed 
mutagenesis using primer pairs ANG2092/ANG2093, ANG2094/ANG2095, 
ANG2096/ANG2097, ANG2098/ANG2099, and ANG2100/ANG2101 and plasmid pET28b-
CBS from strain ANG3218 as a template. The plasmids were initially recovered in strain XL-1 
Blue yielding strains ANG3560 to ANG3564 and subsequently introduced for protein production 
into strain BL21(DE3) yielding strains ANG3565 to ANG3569. Plasmids pET28b-CBSΔ365 and 
pET28b-CBSΔ374 were constructed for the production of C-terminally truncated CBS protein 
variants lacking amino acids 365-408 or 374-408. The respective opuCA fragments were 
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amplified using the primer ANG1842 and either primer ANG2102 or ANG2103 and S. aureus 
LAC* genomic DNA. The resulting PCR fragment was cut and inserted into the NheI and EcoRI 
sites of plasmid pET28b. Plasmids pET28b-CBSΔ365 and pET28b-CBSΔ374 were recovered in E. 
coli XL-1 Blue strains yielding strains ANG3570 and ANG3571 and subsequently introduced 
into E. coli BL21(DE3) giving rise to strains ANG3572 and ANG3573. Plasmid pVL847-
ATPase was constructed for the production and purification of the His-MBP-ATPase fusion 
protein. Primer pair ANG1821/ANG1822 and LAC* genomic DNA were used in a PCR and the 
resulting product cloned into the XhoI and HindIII sites of vector pVL847. The plasmid 
pVL847-ATPase was initially recovered in XL-1 Blue and subsequently introduced for protein 
production and purification into strain BL21(DE3), yielding strains ANG3172 and ANG3173, 
respectively. Plasmids pVL847-SACOL0762, pVL847-SACOL0921, pVL847-SACOL1013 and 
pVL847-SACOL1752 were constructed for the production of the CBS domain containing His-
MBP fusion proteins either because they were not present in the COL ORF library or in order to 
remove transmembrane regions that could possibly impede expression and solubility. Of note, 
while the corresponding genes were amplified from the USA300 strain LAC*, the S. aureus 
strain COL gene nomenclature was used for constancy in naming with the other ORFeome 
library strains. Primer pairs ANG1923/ANG2363, ANG2364/ANG2365, ANG2366/ANG2367 
and ANG1924/ANG1925 and LAC* genomic DNA were used to amplify the respective genes. 
The resulting PCR products were cut and inserted into the XhoI/BamHI sites of plasmid 
pVL847. Plasmids pVL847-SACOL0762, pVL847-SACOL0921, pVL847-SACOL1013 and 
pVL847-SACOL1752 were recovered in E. coli strain XL-1 Blue, resulting in strains ANG4046, 
ANG4047, ANG4048 and ANG3593. The plasmids were then introduced into E. coli strain 
T7IQ for protein production, yielding strains ANG4049, ANG4050, ANG4051, and ANG3597. 
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The sequences of all inserts were verified by automated fluorescence sequencing at GATC 
Biotechnology. 
 
S. aureus strain constructions 
Plasmid pIMAYDopuCA was produced for construction of S. aureus strains with an in-frame 
deletion in opuCA. To this end, the first 30 bases of opuCA plus an approximately 1 kb upstream 
fragment was amplified with primers ANG2028/ANG2029, and the last 30 bases of opuCA plus 
an approximately 1 kb downstream fragment with primers ANG2030/ANG2031 using LAC* 
chromosomal DNA. The fragments were fused by splicing overlap extension (SOE) PCR using 
primers ANG2028 and ANG2031, digested and cloned into EcoRV and NotI sites of plasmid 
pIMAY. Plasmid pIMAYDopuCA was recovered in E. coli strain XL1-Blue, yielding strain 
ANG3580, shuttled through E. coli strain IM08B (58) yielding strain ANG3728, and 
subsequently introduced by electroporation into the strain LAC*. The opuCA gene was deleted 
by allelic exchange as previously described (59), yielding the strain LAC*DopuCA (ANG3744). 
Successful disruption of opuCA was confirmed by PCR. For complementation analysis, the 
single site integration vector pCL55-opuCA was constructed to allow expression of the opuCA 
gene under its native promoter in S. aureus. To this end, the opuCA gene, including a 643 bp 
upstream DNA fragment containing the promoter region, was amplified with primer pair 
ANG2025/ANG2027. The PCR product was partially digested with XmaI as the fragment 
contained an internal XmaI site and fully digested with EcoRI and inserted into vector pCL55, 
which had been cut with the same enzymes. The plasmid pCL55-opuCA was initially recovered 
in E. coli strain XL1 Blue, yielding strain ANG3581. Next the plasmid was transformed into E. 
coli strain IM08B yielding strain ANG3733 and from there introduced by electroporation into S. 
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aureus strain LAC*DopuCA (ANG3744) yielding strain LAC*DopuCA pCL55-opuCA 
(ANG3830). As a control, the empty plasmid vector pCL55 was shuttled through E. coli IM08B 
(ANG3732) and subsequently introduced by electroporation into strains LAC* (ANG1575) and 
LAC*DopuCA (ANG3744), yielding strains LAC* pCL55 (ANG3795) and LAC*DopuCA 
pCL55 (ANG3829). 
 
Protein purifications and SEC-MALS analysis 
Proteins were purified from 1-2 L E. coli cultures. Cultures were grown to an OD600 of 0.5–0.7 at 
37°C, gene expression induced with 0.5 mM IPTG, and cultures incubated overnight at 16°C to 
18°C. Protein purifications were performed by nickel affinity and size exclusion chromatography 
as previously described (16, 60). The His-CBS protein for the protein crystallography work was 
purified by nickel affinity as described above, however a 20 mM Tris-HCl pH 7.5, 50 mM NaCl, 
10 mM MgCl2 buffer was used for the size exclusion purification step. Protein-containing 
fractions were combined and concentrated to 10 mg/ml using a 10 kDa cut-off concentrator 
(Millipore), and protein concentrations were determined by A280 readings or using the Pierce 
BCA protein assay kit. Where indicated, 20 µl of 5 µM solution of the purified proteins were also 
separated on 12% polyacrylamide (PAA) gels and proteins visualized by Coomassie staining. 
For the SEC-MALS analysis, the purified His-OpuCA protein was adjusted to a concentration of 
4 mg/ml in 50mM Tris-HCl pH 7.5, 200mM NaCl, 5% glycerol buffer and loaded on a Superdex 
10/300 size exclusion column, which was coupled to a multi-angle laser light scattering detector 
(Wyatt Technology Corporation). The data were processed with the ASTRA 6.0 software and 
fitted according to the Zimm model for static light scattering. The analysis was performed three 
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For crystallization, sitting-drop trials were performed using 1440 different commercially 
available conditions (Molecular Dimensions and Hampton Research). Plate-shaped crystals 
appeared after 7-10 days at 4°C under several conditions; the best crystals were obtained with 0.2 
M sodium nitrate plus 20% PEG3350. Crystals were flash cooled in liquid nitrogen after serial 
addition of PEG400 in 10% steps to a final concentration of 30%. The details for structure 
solution, refinement, and analysis can be found in the supplementary materials and methods 
section. 
Preparation of E. coli whole-cell lysates 
T7IQ pVL847-Gn S. aureus COL ORFeome library strains were grown overnight at 30°C in LB-
M9 medium. The following morning, the strains were sub-cultured into fresh LB-M9 medium, 
grown for 3 h, and gene expression was induced with 1 mM IPTG. Cultures were then incubated 
for an additional 6 h at 30°C. Bacteria from a 1 ml culture aliquot were collected by 
centrifugation and suspended in lysis buffer (40 mM Tris (pH 7.5), 100 mM NaCl, 10 mM 
MgCl2, 2 mM PMSF, 20 µg/mL DNase, and 0.5 mg/mL lysozyme) in 1/10 of their original 
volume. Cells were lysed by three freeze-thaw cycles. Lysates were directly used in binding 
assays or stored frozen. For E. coli strains expressing the different opuCA variants, the lysates 
were prepared as described above, but the strains were grown overnight at 30°C in 5 ml of LB 
medium. Gene expression was then induced by the addition of 1 mM IPTG to the overnight 
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cultures, incubated for 6 h at 30°C, and cells harvested by centrifugation and suspended to an 
OD600 of 5 in 100 µl lysis buffer. 
For testing the capacity of CBS domain–containing proteins to bind c-di-AMP, strains were 
grown and protein expression induced the same as for the library strains; however lysates were 
subsequently prepared as follows: Bacteria from 5 ml culture was collected by centrifugation, 
suspended in 5 ml spheroplasting buffer (50 mM Tris pH 7.5, 20% Sucrose, 5 mM EDTA, 1 
mg/ml lysozyme), and incubated on ice for 20 min. Spheroplasts were collected by 10 min low-
speed centrifugation at 180 x g, the supernatant removed, and cells subsequently lysed by 
vigorously suspending in 1 ml of cold lysis buffer (5mM Tris pH 7.5). Then DNase I (50 µg/ml) 
and MgCl (20 mM MgCl) were added and the lysate incubated at room temperature for 30 min. 
The lysate was either used directly for nucleotide binding assays or following removal of 
insoluble proteins by centrifugation at 4°C for 1 h at 21,000 x g. 
 
Differential radial capillary action of ligand assay (DRaCALA) 
The principle of the DRaCALA is described in Roelofs et al. (30) and has been adapted for the 
study of c-di-AMP binding proteins by Corrigan et al. (16). Briefly, 9 µl of E. coli whole-cell 
lysates in binding buffer were mixed with ∼1 nM 32P-labeled c-di-AMP, which was synthesized 
in vitro as previously described using the Bacillus thuringiensis DisA enzyme (18). The reactions 
were incubated at room temperature for 5 min and 2.5 µl were spotted onto nitrocellulose 
membranes. For the whole-genome screen, the 32P-labeled c-di-AMP was dispensed into 96-well 
plates containing 20 µl lysates and subsequently spotted onto nitrocellulose membrane using a 
96-well pin tool (V&P Scientific). Membranes were placed into cassettes with phosphor screens, 
and the signal was visualized using a Typhoon 7000 (GE Healthcare). For competition assays, 10 
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µM of purified protein was mixed with 100 µM of the different cold nucleotides [AMP, ADP, 
ATP, GTP (Sigma); cAMP, cGMP, pApA (Biolog); c-di-AMP, c-di-GMP (Invivogen)] and 2.5 
µl of the reaction mixtures were spotted onto nitrocellulose membranes. For DRaCALAs with 
purified protein, 10 µM protein solutions in binding buffer were mixed with ∼1 nM 32P-labeled 
c-di-AMP. For Kd analysis, two-fold dilutions of purified protein solutions giving final 
concentrations ranging from 100 µM to 0.1 µM or 50 µM to 0.1 µM in binding buffer were 
mixed with ∼1 nM 32P-labeled c-di-AMP. For all assays, the purified proteins were incubated 
with the radiolabelled c-di-AMP for 5 min at RT . 2.5 µl of these reaction mixtures were then 
spotted onto nitrocellulose membranes, air-dried, and radioactivity signals detected as described 
above. The fraction of ligand bound and as previously described (30) and the Kd values 
determined using a non-linear regression with Hill coefficient (Y = Bmax * Xh/(Kdh + Xh)).  
 
Uptake of radiolabeled compatible solutes 
The uptake of radiolabeled glycine betaine, choline chloride, and carnitine hydrochloride was 
measured using a previously described method (61, 62) with the following modifications: S. 
aureus strains were grown overnight in CDM with 0.5 M NaCl and the cultures back-diluted the 
following morning to an OD600 of 0.2 OD in 20 ml of CDM with 0.5 M NaCl. Because not all 
strains could be processed at once, cultures were inoculated in a staggered fashion one hour 
apart. The cultures were then grown at 37°C to exponential phase (OD600 ~0.5), at which point a 
culture equivalent of OD = 8 was removed and bacteria collected by centrifugation at 8000 x g 
for 10 min. The supernatants were removed and the cell pellets suspended in 4 ml CDM with 0.5 
M NaCl. Then the OD was measured and the cell density adjusted to an OD600 = 1. Before the 
radiolabeled compound was added, an initial 100 µl aliquot of this cell suspension was applied to 
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a 0.2 µm cellulose nitrate membrane (Millipore), vacuum-filtered, and washed with 17 ml of 
CDM containing 0.5 M NaCl. This sample was used as a measure of background radiation in the 
experimental system. To measure uptake of radiolabeled compounds, betaine [glycine-1-14C] 
(Hartmann Analytic), choline chloride [methyl-14C] (PerkinElmer), or carnitine hydrochloride L-
[N-methyl-14C] (Hartmann Analytic) was added to a final concentration of 25 µM (0.046 MBq / 
1.25 µCi) to the remaining 900 µl of the cell suspension. At 0, 3, and 6 minutes, and in some 
cases every minute, 100 µl aliquots were removed, filtered, and washed with 17 ml of CDM with 
0.5 M NaCl. The membrane filters were added to 9 ml of Filter-Count scintillation fluid 
(PerkinElmer) and radioactivity measured in counts per minute (CPM) using a Wallac 1409 DSA 
liquid scintillation counter. The long-term carnitine uptake experiment with the LAC* wild-type 
and DgdpP strains was done as described above with the following changes: chloramphenicol 
(100 µg/ml) was added to the cell suspensions after their harvest to minimize growth. An initial 
aliquot of 400 µl was removed and 50 µl, instead of 100 µl aliquots, were taken for the 
radioactive uptake measurements. The cells were then incubated at 37°C with shaking. In 
addition, a culture treated identically, but without the addition of radiolabeled carnitine, was used 
to measure at each time point the OD600 to adjust for slight differences in residual growth, which 
occurred despite the addition of chloramphenicol. 
Choline uptake assays were conducted as described by Kiran et al. (37). S. aureus cultures were 
grown overnight in M9 medium containing glucose, casamino acids, and vitamins. The next day, 
the cultures were back-diluted to an OD600 of 0.01 into the same medium and grown until they 
reached an OD600 of 0.2. Next, 2 ml aliquots were transferred to conical tubes and 200 µl of the 
cultures filtered to determine the background radioactivity. Radiolabeled choline was added to 
the remaining culture to a final concentration of 5 µM (0.0102 MBq / 0.2757 µCi). 200 µl 
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samples were filtered at 0, 3 and 6 minutes, washed with 20 ml 0.1 x PBS, and the radioactivity 
on the filter was determined using a scintillation counter. 
 
Detection of OpuCA by western blot 
For the detection of the S. aureus OpuCA protein by western blot, a polyclonal rabbit antibody 
was generated at Covalab using the purified His-CBS proteins (OpuCA aa 207-408) as 
immunogen. Samples for western blot analysis were prepared from S. aureus strains LAC* 
pCL55, LAC*ΔopuCA pCL55 and the LAC*DopuCA pCL55-opuCA as described previously (7), 
with small modifications. Briefly, bacteria from 1 ml S. aureus culture were collected by 
centrifugation (13,000 x g, 5 min) and suspended per OD600 unit in 15 µl of 50 mM Tris-HCl, pH 
7.5, 10 mM MgCl2 buffer containing 100 µg/ml lysostaphin and 20 µg/ml DNase A. The 
samples were incubated for 30 min at 37°C, an equal volume of 2x SDS protein sample loading 
buffer was added and the samples were subsequently boiled for 15 mins. 10 µl samples were 
loaded on a 12% SDS-polyacrylamide gel and proteins separated by electrophoresis, followed by 
electro-transfer onto PVDF membranes. Western-blots were performed using the OpuCA 
antibody (Covalab) and an HRP-conjugated antibody recognizing rabbit IgG (Cell signaling 
technology) at 1:10,000 dilutions. Blots were developed using the Clarity ECL substrate 
(BioRad) and visualized using the ChemiDoc Touch Imaging System (BioRad). 
 
Statistical analyses 
Statistical analyses were done using Prism version 6.0f (Graphpad) and a Kruskal-Wallis test 
followed by a Dunn’s multiple comparison test was performed on the data sets as indicated in 
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each legend. Adjusted p-values < 0.01 are indicated by double asterisk (**) and p-values <0.05 
by a single asterisk (*). 
 
SUPPLEMENTARY MATERIALS 
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Fig. S2. DRaCALAs with cleared cell lysates derived from E. coli strains producing different 
CBS domain–containing S. aureus proteins. 
Fig. S3. Oligomeric state of the S. aureus OpuCA CBS domain in the crystal structure and in 
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Fig. S4. Structure-based sequence alignment of the S. aureus OpuCA CBS domain with other 
ligand-bound CBS domains 
Fig. S5. OpuCA protein amounts in wild-type S. aureus, mutant, and complementation strains 
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Fig. 1. c-di-AMP interacts specifically and with physiological strength with OpuCA. 
Schematic representations of (A) the opuCA-opuCD operon structure and (B) the OpuC ATP-
binding cassette osmoprotectant uptake system. (C) Binding curve and Kd determination between 
c-di-AMP and OpuCA. Radiolabeled c-di-AMP and purified His-MBP-OpuCA protein were 
used in DRaCALAs, the median fraction bound values and ranges were plotted, and the curve 
fitted and Kd value determined using a non-linear equation with hill coefficient (n=4, two 
independent protein purifications). (D) Nucleotide binding competition assays. Purified His-
MBP-OpuCA was incubated with radiolabeled 1 nM c-di-AMP and 100 µM unlabelled 
competitor nucleotide. The median fraction bound values and ranges were determined and 
plotted (n=8, two independent protein purifications). Statistical analysis was done using a 
Kruskal-Wallis test, followed by Dunn’s multiple comparison test. Adjusted p-values < 0.01 are 
indicated by double asterisk (**). 
		 42	
 
Fig. 2. c-di-AMP interacts specifically with the CBS pair domain of OpuCA. (A) Schematic 
representation of the full-length His-MBP-OpuCA (top), His-MBP-ATPase (middle) and His-
CBS (bottom) fusion proteins. (B) Coomassie stained gel showing the purified fusion proteins 
indicated above each lane (n=2, two independent protein purifications). (C) DRaCALA spots. 
The purified proteins shown in (B) were mixed with radiolabeled c-di-AMP and spotted onto 
nitrocellulose membranes. Spots were visualized using a phosphor imager (n=2, two independent 
protein purifications). (D) Binding curve and Kd determination. Radiolabeled c-di-AMP and 
purified His-CBS protein were used in DRaCALAs and Kd value determined using a non-linear 
equation with hill coefficient (n=5, two independent protein purifications). (E) Nucleotide 
binding competition assays. Competition assays were performed as described for Figure 1 (n=8, 
two independent protein purifications). Statistical analysis was first done using a Kruskal-Wallis 
test, followed by Dunn’s multiple comparison test. Adjusted p-values < 0.01 are indicated by 






Fig. 3. c-di-AMP does not bind to other S. aureus CBS domain containing proteins. (A) 
ClustalW alignments of the CBS domains found in the seven different S. aureus proteins. Only 
the CBS domain pair region plus 10 amino acids flanking each end was used for the alignment. 
(B) Coomassie stained gel showing lysates from E. coli strains overproducing the His-MBP 
control protein (lane 1) or His-MBP-fusion to the S. aureus protein indicated above each of the 
other lanes were separated on a polyacrylamide gel and visualized by Coomassie staining (n=4). 
For the membrane proteins SACOL0762, SACOL0921, and SACOL1013, His-MBP fusion 
proteins to the CBS domain only, but lacking the transmembrane regions, were used. (C) 




Fig. 4. Structure of the S. aureus OpuCA CBS domain and putative c-di-AMP binding site. 
(A) Crystal structure of a monomer of the S. aureus OpuCA CBS domain. (B) Sample of the 
electron density map showing the potential c-di-AMP binding site. (C) Overlay of the S. aureus 
OpuCA CBS domain (green) and the M. jannaschii MJ0100 protein (purple) (rmsd = 1.7 Å). The 
SAM ligand in the MJ0100 protein is depicted in light green. A close-up view of the SAM 
binding site is shown on the right. The side chains of Asp439 and Ile434 in MJ0100, which are 
involved in SAM binding, and the side chains of Phe283 and Phe294 in OpuCA, which are 
putatively involved in c-di-AMP binding, are shown as sticks. (D) Electrostatic surface analysis 
of the S. aureus OpuCA CBS domains (left) and the SAM-bound MJ0100 protein (right). 
Positively and negatively charged areas are coloured in blue and red, respectively. The putative 
c-di-AMP binding groove in OpuCA and the SAM binding region in MJ0100 are marked with 
white asterisks (*). 
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Fig. 5. Amino acids within the OpuCA CBS domain that are critical for c-di-AMP binding. 
(A) Lysates from E. coli strains overproducing the His-CBS variants containing amino acids 
substitutions or C-terminal deletions, as well as lysates from the positive control His-CBS 
protein (WT) and the negative control (pET28b), separated on Coomassie stained 
polyacrylamide gel (n=6). (B) DRaCALAs with whole cell lysates shown in panel (A) and 
radiolabeled c-di-AMP. Representative spots are shown as well as the median fraction bound 
values and ranges (n=6). (C) Binding curve and Kd determination. Radiolabeled c-di-AMP and 
the purified His-CBS, His-CBSF283A (F283A), and His-CBSF294A (F294A) were used in 
DRaCALAs. Curves were fitted as in Fig. 1C and the Kd for c-di-AMP and the WT His-CBS 
protein determined. Kd values could not be determined for His-CBSF283A and His-CBSF294A 
because these variants showed reduced binding to c-di-AMP (WT: n=5, F283A & F294A: n=6, 
two independent protein purifications for each protein). Statistical analysis was done using a 
Kruskal-Wallis test, followed by Dunn’s multiple comparison test. Adjusted p-values are 




Fig. 6. The S. aureus OpuC transporter is a carnitine uptake system, and cellular c-di-AMP  
impacts carnitine uptake. Uptake of the compatible solutes in M9 (A) or CDM (chemically 
defined medium) (B-E). (A) Choline uptake in M9, (B) choline uptake in CDM (C) glycine 
betaine uptake in CDM, and (D) carnitine uptake in CDM was measured for the S. aureus strains 
LAC* pCL55 (WT), the opuCA mutant LAC*ΔopuCA pCL55 (DopuCA), and the 
complementation strain LAC*DopuCA pCL55-opuCA (opuCA compl.). Radiolabeled compatible 
solutes were added, aliquots were removed at the indicated time points, filtered, and the 
accumulated radioactivity measured. (E) Effect of c-di-AMP on carnitine uptake. Carnitine 
uptake was measured over a period of 4h for the strain LAC* (WT) and the high c-di-AMP strain 
LAC*DgdpP (DgdpP). Median values with ranges are plotted (n=3 for choline, all others n=4). 
Statistical analysis was performed using a Kruskal-Wallis test followed by Dunn’s multiple 
comparison test (against WT at each time point). Adjusted p-values are indicated by asterisks (*), 
with * p < 0.05, ** p < 0.01. 
